Search research articles
Contact Us
Filters
Showing results (31-40 of 70) with videos related to
Page
of 7
Sort By:
European Heart Journal
|
October 12, 2017
Reduction of low density lipoprotein-cholesterol and cardiovascular events with proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors and statins: an analysis of FOURIER, SPIRE, and the Cholesterol Treatment Trialists Collaboration
Brian A Ference, Christopher P Cannon, Ulf Landmesser, et al.
JAMA Cardiology
|
October 24, 2019
Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review
Allan D Sniderman, George Thanassoulis, Tamara Glavinovic, et al.
Atherosclerosis
|
June 12, 2020
Health economic evaluation of screening and treating children with familial hypercholesterolemia early in life: Many happy returns on investment?
Zanfina Ademi, Richard Norman, Jing Pang, et al.
Plos Medicine
|
March 24, 2020
Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis
Tom G Richardson, Eleanor Sanderson, Tom M Palmer, et al.
The American Journal of Cardiology
|
April 3, 2012
Role of non-high-density lipoprotein cholesterol in predicting cerebrovascular events in patients following myocardial infarction
Nitin Mahajan, Brian A Ference, Natasha Arora, et al.
JAMA
|
September 28, 2016
Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Michael G Silverman, Brian A Ference, Kyungah Im, et al.
Atherosclerosis
|
October 16, 2022
Genetic proxies for PCSK9 inhibition associate with lipoprotein(a): Effects on coronary artery disease and ischemic stroke
Gian Marco De Marchis, Tolga D Dittrich, Rainer Malik, et al.
Circulation
|
September 19, 2019
Association Between Triglyceride Lowering and Reduction of Cardiovascular Risk Across Multiple Lipid-Lowering Therapeutic Classes: A Systematic Review and Meta-Regression Analysis of Randomized Controlled Trials
Nicholas A Marston, Robert P Giugliano, KyungAh Im, et al.
European Journal of Preventive Cardiology
|
June 23, 2021
Is the SMART risk prediction model ready for real-world implementation? A validation study in a routine care setting of approximately 380 000 individuals
Ailsa J McKay, Laura H Gunn, Brian A Ference, et al.
Journal of the American College of Cardiology
|
October 23, 2012
Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a Mendelian randomization analysis
Brian A Ference, Wonsuk Yoo, Issa Alesh, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 70) with videos related to
Sort By:
Page
of 7
European Heart Journal
|
October 12, 2017
Reduction of low density lipoprotein-cholesterol and cardiovascular events with proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors and statins: an analysis of FOURIER, SPIRE, and the Cholesterol Treatment Trialists Collaboration
Brian A Ference, Christopher P Cannon, Ulf Landmesser, et al.
JAMA Cardiology
|
October 24, 2019
Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review
Allan D Sniderman, George Thanassoulis, Tamara Glavinovic, et al.
Atherosclerosis
|
June 12, 2020
Health economic evaluation of screening and treating children with familial hypercholesterolemia early in life: Many happy returns on investment?
Zanfina Ademi, Richard Norman, Jing Pang, et al.
Plos Medicine
|
March 24, 2020
Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis
Tom G Richardson, Eleanor Sanderson, Tom M Palmer, et al.
The American Journal of Cardiology
|
April 3, 2012
Role of non-high-density lipoprotein cholesterol in predicting cerebrovascular events in patients following myocardial infarction
Nitin Mahajan, Brian A Ference, Natasha Arora, et al.
JAMA
|
September 28, 2016
Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Michael G Silverman, Brian A Ference, Kyungah Im, et al.
Atherosclerosis
|
October 16, 2022
Genetic proxies for PCSK9 inhibition associate with lipoprotein(a): Effects on coronary artery disease and ischemic stroke
Gian Marco De Marchis, Tolga D Dittrich, Rainer Malik, et al.
Circulation
|
September 19, 2019
Association Between Triglyceride Lowering and Reduction of Cardiovascular Risk Across Multiple Lipid-Lowering Therapeutic Classes: A Systematic Review and Meta-Regression Analysis of Randomized Controlled Trials
Nicholas A Marston, Robert P Giugliano, KyungAh Im, et al.
European Journal of Preventive Cardiology
|
June 23, 2021
Is the SMART risk prediction model ready for real-world implementation? A validation study in a routine care setting of approximately 380 000 individuals
Ailsa J McKay, Laura H Gunn, Brian A Ference, et al.
Journal of the American College of Cardiology
|
October 23, 2012
Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a Mendelian randomization analysis
Brian A Ference, Wonsuk Yoo, Issa Alesh, et al.
Page
of 7